MIRA
INFORM REPORT
|
Report Date : |
19.08.2008 |
IDENTIFICATION
DETAILS
|
Name : |
LABIALFARMA-LABORATORIO DE PRODUTOS FARMACEUTICOS E NUTRACEUTICOS SA |
|
|
|
|
Registered Office : |
Felgueira, Edifício Labialfarma 1 Mortagua |
|
|
|
|
Country : |
Portugal |
|
|
|
|
Financials (as on) : |
31.12.2006 |
|
|
|
|
Date of Incorporation : |
06.05.1992 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacture
of Pharmaceutical Preparations |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
Euros 49.880,00 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Identification
Name LABIALFARMA-LABORATORIO DE PRODUTOS FARMACEUTICOS E NUTRACEUTICOS SA
Address Felgueira, Edifício Labialfarma 1
Locality MORTAGUA
Postal Code 3450-336-SOBRAL MRT
Telephone 231927590
Fax 231929165
E-Mail labialfarma@labialfarma.com/ email@labialfarma.com
Web Site www.labialfarma.com
V.A.T. Number / NIF 502755954
C.A.E. 24422- Manufacture of pharmaceutical preparations
All the amounts are express
in Euros, otherwise you will be advised
Summary
Legal Form Joint
Stock Company
Constitution 06-05-1992
V.A.T. Number / NIF 502755954
Employees 150
Capital 1.500.000,00
Sales in : 31-12-2006 8.259.488,00
Shareholders Funds in: 31-12-2006 2.976.264,00
Credit Recommended
Credit Limit 49.880,00
Condition Normal
Tendency Stationary
Financing Guaranteed
Payments Good
Actual Condition In
activity
Governing
Bodies
Board of Director's
AMILCAR JOSE DOS
REIS FERRAZ Shareholder and Board of Director's Pres.
MARIA DE LURDES
RIBEIRO DA SILVA FERRAZ Shareholder and Administrator
Fiscal Board
CARLOS ALBERTO DA
SILVA E CUNHA Fiscal Board Substitute
MARQUES DE ALMEIDA
F.TAVARES J.NUNES & V.SIMOES-SROC Unique Fiscal
Banks
and Financial Institutions
MILLENNIUM BCP Mortagua
CAIXA GERAL DE
DEPOSITOS, SA Mortágua
BANIF - BANCO
INTERNACIONAL DO FUNCHAL, SA Mortágua
BANCO SANTANDER
TOTTA SA Tondela
Historical
Registed on the Register
Record Office of Mortagua with the Register Number 502755954 38 in 06-05-1992
Constitution celebrated in
06-05-1992 published on Diário da República number 143 of 24-06-1992
To oblige the company it is
necessary 1 signatures
Changes
to Society
In 20-04-2007 on Portal MJ
of 27-04-2007 change in to a joint stock company
In 02-01-2007 on Portal MJ of 10-01-2007 denomination change de
Labialfarma-Laboratório de Biologia Alimentar e Farmacêutica Lda para
Labialfarma-Laboratório de Produtos Farmacêuticos e Nutraceuticos Lda
In 19-12-2002 on Diário da
República number 67 of 20-03-2003 increase of capital para 250.000 €
In 03-12-1993 on Diário da
República number 13 of 17-01-1994 increase of capital
Capital
The Capital is 1.500.000,00 , divided in 1500000
shares , with a nominal value of 1,00
with the following
shareholders
AMILCAR JOSE DOS
REIS FERRAZ
MARIA DE LURDES
RIBEIRO DA SILVA FERRAZ
Insurance
Company
Companhia de Seguros Fidelidade Mundial
Activities
Line of Business Percentage
Laboratory of alimentary and pharmaceutical biology 100%
|
Type of Clients |
Hospitals/Pharmacies |
|
|
|
Sales Conditions |
Cash/credit |
|
|
|
Sales Area |
|
|
|
|
Country |
100% |
|
|
Employees
Total 150
Head
Office and Installations
Head office and factory Felgueira, Edifício
Labialfarma 1, MORTAGUA, 3450-336, SOBRAL MRT, Tel:231927590, Fax:231929165
Incidents
|
Legal Actions |
||
|
Date: 21-06-2007 |
Judicial District
Matosinhos |
5 Court |
|
Amount: 10.352,61 Euro |
Type: Sumária |
|
|
Author: Zeus Quimica Lda |
|
|
|
Process: 5101/07.1TBMTS |
|
|
|
|
||
|
|
||
|
|
||
|
Date: 12-01-2005 |
Judicial District Cascais |
1 Court |
|
|
Type: Sumária |
|
|
Author: Capsifar, Comércio P. Q. Farmaceiticos, Lda |
|
|
|
Process: 586/05.3TBCSC |
|
|
|
|
||
|
Observations: inj 886/04 |
||
|
|
||
|
Date: 18-06-2004 |
Judicial District Porto |
3 Court 2 Section |
|
|
Type: Sumária |
|
|
Author: Empresa O Primeiro de Janeiro, Sa |
|
|
|
Process: 13161/04.0TJPRT |
|
|
|
|
||
|
|
||
|
|
||
|
Date: 29-01-2003 |
Judicial District Coimbra |
05 Court |
|
|
Type: Especial Cump.Obrig. Pecuniarias DL 269/98 |
|
|
Author: Iriscoimbra-Brindes Publicitários |
|
|
|
|
|
|
|
|
||
|
|
||
|
|
||
Credit Recommendation
Consulted sources say that
the subject has been respecting its payments and commercial commitments, so credit
connections with this company are recommended.
Financial
Elements
|
|
31-12-2006 |
|
|
Intangible Assets |
232.072,00 |
|
|
Tangible Assets |
3.239.100,00 |
|
|
Stocks |
1.336.723,00 |
|
|
Short Term Receivable |
2.863.219,00 |
|
|
Banks and Cash |
96.232,00 |
|
|
Accruals and Deferrals |
54.849,00 |
|
|
Total Assets |
7.822.195,00 |
|
|
Shareholder's Funds |
2.976.264,00 |
|
|
Short Term Payable |
4.457.373,00 |
|
|
Accruals and Deferrals |
388.558,00 |
|
|
Total Liabilities and Shareholder's Funds |
7.822.195,00 |
|
|
Cost of Goods and Consumable Materials |
2.237.976,00 |
|
|
Outside Supplies and Services |
1.539.746,00 |
|
|
Personnel Costs |
3.151.262,00 |
|
|
Sales |
8.259.488,00 |
|
Comparatives
|
|
31-12-2004 |
31-12-2005 |
31-12-2006 |
|
Net Sales |
6.434.944,00 |
7.930.547,00 |
8.259.488,00 |
|
Net Income For the Year |
96.849,00 |
373.018,00 |
276.714,00 |
|
Current Assets |
2.741.163,00 |
3.396.801,00 |
4.351.023,00 |
|
Short Term Payables |
3.236.906,00 |
3.902.190,00 |
4.457.373,00 |
|
Cash Flow |
(495.743,00) |
(505.389,00) |
(106.350,00) |
|
Total Assets |
5.229.493,00 |
6.937.343,00 |
7.822.195,00 |
|
Total Liabilities |
3.577.900,00 |
4.237.795,00 |
4.845.931,00 |
|
Shareholders Funds |
1.651.594,00 |
2.699.550,00 |
2.976.264,00 |
|
Personnel Costs |
2.348.284,00 |
2.815.258,00 |
3.151.262,00 |
Ratios
|
|
31-12-2004 |
31-12-2005 |
31-12-2006 |
|
FINANCIAL SITUATION |
|
|
|
|
General Liquidity |
0,85 |
0,87 |
0,98 |
|
Immediate Liquidity |
0,54 |
0,57 |
0,68 |
|
Financial Autonomy |
0,32 |
0,39 |
0,38 |
|
Solvency |
0,46 |
0,64 |
0,61 |
|
RENTABILITY |
|
|
|
|
Sales Rentability |
1,51 % |
4,70 % |
3,35 % |
|
Sales Rate Increase |
|
23,24 % |
4,15 % |
|
EFFICIÊNCY |
|
|
|
|
Assets Turnover |
1,23 |
1,14 |
1,06 |
Balance
Sheet and Income Statement
|
Balance Sheet |
||
|
CoinEURO |
|
Date31-12-2006 |
|
|
||
|
|
Gross Assets |
Depreciations /
Provisions |
Net Assets |
|
Intangible Assets |
|
Subtotal |
498.834,00 |
266.762,00 |
232.072,00 |
|
Tangible Assets |
|
Subtotal |
6.454.867,00 |
3.215.767,00 |
3.239.100,00 |
|
Stocks |
|
Subtotal |
1.336.723,00 |
|
1.336.723,00 |
|
Short
Term Receivable |
|
Subtotal |
2.988.675,00 |
125.456,00 |
2.863.219,00 |
|
Bank
Deposits and Cash |
|
Cash |
45.185,00 |
|
45.185,00 |
|
Bank Deposites |
51.047,00 |
|
51.047,00 |
|
Subtotal |
96.232,00 |
|
96.232,00 |
|
Accruals
and Deferrals |
|
Accrued Income |
43.652,00 |
|
43.652,00 |
|
Deferred Cost |
11.197,00 |
|
11.197,00 |
|
Subtotal |
54.849,00 |
|
54.849,00 |
|
|
|
Total Assets |
11.430.180,00 |
3.607.985,00 |
7.822.195,00 |
|
Shareholders
Funds and Liabilities |
|
Shareholders Funds |
|
Capital |
250.000,00 |
|
|
Treasury Stock: |
|
|
|
Reserves : |
|
|
|
Legal |
674.938,00 |
|
|
Free |
268.491,00 |
|
|
Net Retained |
1.506.121,00 |
|
|
Net Income For the Year |
276.714,00 |
|
|
Total |
2.976.264,00 |
|
|
Short
Term Payable |
|
Bank Loans |
1.241.653,00 |
|
|
Supliers Fixed Asset |
917.306,00 |
|
|
State and Other Public
Bodies |
372.968,00 |
|
|
Other Creditors |
342.019,00 |
|
|
Trade Creditors |
1.129.738,00 |
|
|
Trade Notes Payable |
244.099,00 |
|
|
Shareholders |
209.591,00 |
|
|
Subtotal |
4.457.373,00 |
|
|
Accruals
and Deferrals |
|
Accrued Charges |
388.558,00 |
|
|
Subtotal |
388.558,00 |
|
|
TOTAL LIABILITIES |
4.845.931,00 |
|
|
TOTAL LIABILITIES AND
SHAREHOLDERS FUNDS |
7.822.195,00 |
|
|
Income
Statement |
|
Costs
and Losses |
|
Cost of : |
|
|
|
Subtotal |
2.237.976,00 |
|
|
Outside Supplies and
Services |
1.539.746,00 |
|
|
Personnel Costs |
|
|
|
Subtotal |
3.151.262,00 |
|
|
Depreciation |
709.786,00 |
|
|
Provisions |
84.969,00 |
|
|
Subtotal |
794.755,00 |
|
|
Other Operating Costs |
24.046,00 |
|
|
Int. and Similar Costs: |
|
|
|
Subtotal |
290.266,00 |
|
|
Ext. Costs and Losses |
59.994,00 |
|
|
Taxation Over Income |
116.105,00 |
|
|
Net Income For the Year |
276.714,00 |
|
|
Income
and Profits |
|
Sales of : |
|
|
|
Products |
8.135.388,00 |
|
|
Services Provided |
124.100,00 |
|
|
Subtotal |
8.259.488,00 |
|
|
Variation in Production |
49.006,00 |
|
|
Trading Securities Income
|
|
|
|
Int. and Similar Costs |
|
|
|
Other |
165.617,00 |
|
|
Extra Income and Gains |
16.753,00 |
|
|
Net Income For the Year |
276.714,00 |
|
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.23 |
|
UK Pound |
1 |
Rs.80.89 |
|
Euro |
1 |
Rs.63.80 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)